Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Protagonist Therapeutics
PTGX
$3.66B
| $942K | ﹤0.01% |
32,567
-181,400
| -85% | -$5.25M |
|
2527
GrafTech
EAF
$261M
| $933K | ﹤0.01% |
67,610
-53,800
| -44% | -$742K |
|
2528
iShares Core US REIT ETF
USRT
$3.16B
| $931K | ﹤0.01% |
17,300
+7,700
| +80% | +$414K |
|
2529
Marten Transport
MRTN
$953M
| $929K | ﹤0.01% |
50,266
+20,766
| +70% | +$384K |
|
2530
Brighthouse Financial
BHF
$2.8B
| $928K | ﹤0.01% |
+18,000
| New | +$928K |
|
2531
Vanguard Industrials ETF
VIS
$6.13B
| $928K | ﹤0.01% |
3,800
-300
| -7% | -$73.3K |
|
2532
SPDR Euro Stoxx 50 ETF
FEZ
$4.59B
| $925K | ﹤0.01% |
17,600
-9,800
| -36% | -$515K |
|
2533
Invesco Aerospace & Defense ETF
PPA
$6.29B
| $924K | ﹤0.01% |
9,100
-15,300
| -63% | -$1.55M |
|
2534
MaxLinear
MXL
$1.37B
| $922K | ﹤0.01% |
49,391
-204,013
| -81% | -$3.81M |
|
2535
Sight Sciences
SGHT
$181M
| $922K | ﹤0.01% |
174,656
+97,256
| +126% | +$513K |
|
2536
Myomo
MYO
$31.9M
| $921K | ﹤0.01% |
281,700
+88,100
| +46% | +$288K |
|
2537
Schwab U.S Small- Cap ETF
SCHA
$18.9B
| $921K | ﹤0.01% |
+37,400
| New | +$921K |
|
2538
First US Bancshares
FUSB
$69.1M
| $919K | ﹤0.01% |
99,221
-2,800
| -3% | -$25.9K |
|
|
SCTL
2539
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $918K | ﹤0.01% |
850,317
+19,100
| +2% | +$20.6K |
|
2540
Solid Biosciences
SLDB
$420M
| $916K | ﹤0.01% |
68,771
+30,700
| +81% | +$409K |
|
2541
Sibanye-Stillwater
SBSW
$6.17B
| $915K | ﹤0.01% |
+194,200
| New | +$915K |
|
2542
Cumberland Pharmaceuticals
CPIX
$51.5M
| $912K | ﹤0.01% |
542,663
-7,200
| -1% | -$12.1K |
|
2543
Moog Class B
MOG.B
| $911K | ﹤0.01% |
5,800
-100
| -2% | -$15.7K |
|
2544
US Physical Therapy
USPH
$1.22B
| $908K | ﹤0.01% |
8,049
-7,600
| -49% | -$857K |
|
2545
Rallybio
RLYB
$25.1M
| $903K | ﹤0.01% |
+488,100
| New | +$903K |
|
2546
Zevra Therapeutics
ZVRA
$435M
| $901K | ﹤0.01% |
155,400
-15,100
| -9% | -$87.5K |
|
2547
Fidelity Wise Origin Bitcoin Fund
FBTC
$15.4B
| $900K | ﹤0.01% |
+14,500
| New | +$900K |
|
2548
Avantis International Equity ETF
AVDE
$8.98B
| $899K | ﹤0.01% |
+14,100
| New | +$899K |
|
|
WKME
2549
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $899K | ﹤0.01% |
104,500
+41,700
| +66% | +$359K |
|
2550
Mistras Group
MG
$299M
| $897K | ﹤0.01% |
93,800
+9,500
| +11% | +$90.8K |
|